Skip to main content
NCBI home page
The Kaohsiung Journal of Medical Sciences logoLink to The Kaohsiung Journal of Medical Sciences
. 2009 Jul 20;19(8):406–414. doi: 10.1016/S1607-551X(09)70484-X

Potential Role of Vascular Endothelial Growth Factor, Interleukin‐8 and Monocyte Chemoattractant Protein‐1 in Periodontal Diseases

En Lee 1, Ya‐Ping Ho 1, Kun‐Yen Ho 1, Chi‐Cheng Tsai 1,✉, Yi‐Hsin Yang 1,2
PMCID: PMC11917697  PMID: 12962428

Abstract

Host‐mediated immunoinflammatory pathways activated by bacteria lead to destruction of the periodontal connective tissues and alveolar bone. The objective of this study was to elucidate the activation of the inflammatory processes in periodontal disease by quantitative assessment of cytokines and periodontopathogens. Gingival crevicular fluids (GCF) and subgingival plaque samples were collected from patients with chronic periodontitis and gingivitis and from periodontally healthy sites. Vascular endothelial growth factor (VEGF), monocyte chemoattractant protein‐1 (MCP‐1), and interleukin 8 (IL‐8) in GCF were analyzed by enzyme‐linked immunosorbent assay. Periodontopathogens, including Bacteroides forsythus, Campylobacter rectus, Porphyromonas gingivalis and Prevotella intermedia, were analyzed by immunofluorescence and dark‐field microscopy. There was significantly more VEGF and IL‐8 in chronic periodontitis and gingivitis sites than in periodontally healthy sites. There were significant positive correlations between the concentrations and total amounts of VEGF and IL‐8 in chronic periodontitis and gingivitis sites, and between the levels of periodontopathogens and the total amounts of VEGF, MCP‐1 and IL‐8. These data indicate that inflammatory processes induced by periodontopathogens and the activation of certain cytokines (VEGF, MCP‐1, IL‐8) in periodontal diseases may be relevant to host‐mediated destruction in chronic periodontitis.

Keywords: vascular endothelial growth factor, cytokines, chemokines, periodontopathogens, periodontal disease

Full Text

The Full Text of this article is available as a PDF (130.0 KB).

References

  • 1. Page RC. Milestones in periodontal research and the remaining critical issues. J Periodontal Res. 1999; 34: 331–339. [DOI] [PubMed] [Google Scholar]
  • 2. Dinarello CA. Interleukin‐1 and interleukin‐1 antagonism. Blood. 1991; 77: 1627–1652. [PubMed] [Google Scholar]
  • 3. Rossomando EF, Kennedy JE, Hadjimichael J. Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol. 1990; 35: 431–434. [DOI] [PubMed] [Google Scholar]
  • 4. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res. 1991; 26: 230–242. [DOI] [PubMed] [Google Scholar]
  • 5. Bickel M. The role of interleukin‐8 in inflammation and mechanisms of regulation. J Periodontol. 1993; 64 (5 Suppl): 456–460. [PubMed] [Google Scholar]
  • 6. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodontol. 1998; 3: 108–120. [DOI] [PubMed] [Google Scholar]
  • 7. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel formation. J Cell Biochem. 1991; 47: 219–223. [DOI] [PubMed] [Google Scholar]
  • 8. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability and angiogenesis. Am J Pathol. 1995; 146: 1029–1039. [PMC free article] [PubMed] [Google Scholar]
  • 9. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998; 392: 565–568. [DOI] [PubMed] [Google Scholar]
  • 10. Graves DT. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis. 1999; 28: 482–490. [DOI] [PubMed] [Google Scholar]
  • 11. Cushing SFA. Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein. Arterioscler Thromb Vasc Biol. 1992; 12: 78–82. [DOI] [PubMed] [Google Scholar]
  • 12. Yla‐Herttuala S, Lipton A, Rosenfeld M, et al. Expression of monocyte chemoattractant protein 1 in macrophage‐rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA. 1992; 89: 6953–6957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Yu X, Barnhill R, Graves DT. Expression of monocyte chemoattractant protein‐1 (MCP‐1) in delayed type hypersensitivity reactions in the skin. Lab Invest. 1994; 71: 226–235. [PubMed] [Google Scholar]
  • 14. Graves DT, Barnhill R, Galanopoulos T, Antoniades HN. Expression of monocyte chemotactic protein‐1 in human melanoma in vivo. Am J Pathol. 1992; 140: 9–14. [PMC free article] [PubMed] [Google Scholar]
  • 15. Villiger P, Terkeltaub R, Lotz M. Production of monocyte chemoattractant protein‐1 by inflamed synovial tissue and cultured synoviocytes. J Immunol. 1992; 149: 722–727. [PubMed] [Google Scholar]
  • 16. Graves DT, Barnhill R, Galanopoulos T, Antoniades HN. Fibroblasts, mononuclear phagocytes and endothelial cells express MCP‐1 in inflamed human gingiva. J Periodontol. 1995; 66: 80–88. [DOI] [PubMed] [Google Scholar]
  • 17. Rahimi P, Wang C, Stashenko P, et al. MCP‐1 expression and monocyte recruitment in osseous inflammation. Endocrinology. 1995; 136: 2752–2759. [DOI] [PubMed] [Google Scholar]
  • 18. Hanazawa S, Kawata Y, Takeshita A, et al. Expression of monocyte chemoattractant protein 1 (MCP‐1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP‐1 expression in gingival tissues. Infect Immun. 1993; 61: 5219–5224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Miyasaki KT. The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol. 1991; 62: 761–774. [DOI] [PubMed] [Google Scholar]
  • 20. Tsai CC, Ho YP, Chen CC. Levels of interleukin‐1 beta and interleukin‐8 in gingival crevicular fluids in adult periodontitis. J Periodontol. 1995; 66: 852–859. [DOI] [PubMed] [Google Scholar]
  • 21. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odont Scand. 1964; 24: 747–759. [DOI] [PubMed] [Google Scholar]
  • 22. Löe H. The gingival index, plaque index and the retention index systems. J Periodontol. 1967; 38: 610–616. [DOI] [PubMed] [Google Scholar]
  • 23. Polson AM, Caton JG, Yeaple RN, Zander HA. Histological determination of probe tip penetration into gingival sulcus of humans using an electronic pressure‐sensitive probe. J Clin Periodontol. 1980; 7: 479–488. [DOI] [PubMed] [Google Scholar]
  • 24. Stroller NH, Karras DC, Johnson LR. Reliability of crevicular fluid measurements taken in the presence of supragingival plaque. J Periodontol. 1990; 61: 670–673. [DOI] [PubMed] [Google Scholar]
  • 25. Wolff LF, Dahlèn G, Aeppli D. Bacteria as risk markers for periodontitis. J Periodontol. 1994; 64: 498–510. [DOI] [PubMed] [Google Scholar]
  • 26. Lai CH, Listgarten MA, Shirakawa M, Slots J. Bacteroides forsythus in adult gingivitis and periodontitis. Oral Microbiol Immunol. 1987; 5: 115–132. [DOI] [PubMed] [Google Scholar]
  • 27. Eley BM, Cox SW. Cathepsin B/L‐, elastase‐, tryptase‐, trypsin‐ and dipeptidyl peptidase IV‐like activities in gingival crevicular fluid: correlation with clinical parameters in untreated chronic periodontitis patients. J Periodont Res. 1992; 27: 62–69. [DOI] [PubMed] [Google Scholar]
  • 28. Booth V, Young S, Cruchley AT, et al. Vascular endothelial growth factor in human periodontal disease. J Periodontal Res. 1998; 33: 491–499. [DOI] [PubMed] [Google Scholar]
  • 29. Taichman NS, Young S, Cruchley AT, et al. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol. 1997; 62: 397–400. [DOI] [PubMed] [Google Scholar]
  • 30. Offenbacher S, Collins JG, Heasman PA. Diagnostic potential of host response mediators. Adv Dent Res. 1993; 7: 175–181. [DOI] [PubMed] [Google Scholar]
  • 31. Ben‐Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995; 372: 83–87. [DOI] [PubMed] [Google Scholar]
  • 32. Hanatani M, Tanaka Y, Kondo S, et al. Sensitive chemiluminescence immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotechnol Biochem. 1995; 59: 1958–1959. [DOI] [PubMed] [Google Scholar]
  • 33. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol. 1999; 70: 848–852. [DOI] [PubMed] [Google Scholar]
  • 34. Yu X, Antoniades HN, Graves DT. Expression of monocyte chemoattractant protein‐1 in human inflamed gingival tissues. Infect Immun. 1993; 61: 4622–4628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Yu X, Graves DT. Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein‐1 (MCP‐1) in inflamed human gingiva. J Periodontol. 1995; 66: 80–88. [DOI] [PubMed] [Google Scholar]
  • 36. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein‐1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992; 148: 2423–2428. [PubMed] [Google Scholar]
  • 37. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte immigration: the multistep paradigm. Cell. 1994; 76: 301–304. [DOI] [PubMed] [Google Scholar]
  • 38. Jiang Y, Russell TR, Graves DT, et al. Monocyte chemoattractant protein 1 and interleukin‐8 production in mononuclear cells stimulated by oral microorganisms. Infect Immun. 1996; 64: 4450–4455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Jiang Y, Graves DT. Periodontal pathogens stimulate CC‐chemokine production by mononuclear and bone‐derived cells. J Periodontol. 1999; 70: 1472–1478. [DOI] [PubMed] [Google Scholar]
  • 40. Ward SG, Westwick J. Chemokines: understanding their role in T‐lymphocyte biology. Biochem J. 1998; 333 (Pt 3): 457–470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Mathur A, Michalowicz B, Castillo M, Aeppli D. Interleukin‐1 alpha, interleukin‐8 and interferon‐alpha levels in gingival crevicular fluid. J Periodontal Res. 1996; 31: 489–495. [DOI] [PubMed] [Google Scholar]
  • 42. Darveau RP, Belton CM, Reife RA, Lamont RJ. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun. 1998; 66: 1660–1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Mikolajczyk‐Pawlinska J, Travis J, Potempa J. Modulation of interleukin‐8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett. 1998; 440: 282–286. [DOI] [PubMed] [Google Scholar]

Articles from The Kaohsiung Journal of Medical Sciences are provided here courtesy of Kaohsiung Medical University and John Wiley & Sons Australia, Ltd

RESOURCES